Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies
about
Defective immunoglobulin A (IgA) glycosylation and IgA deposits in patients with IgA nephropathyIdentification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cellsA Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in CancerThe Origin and Activities of IgA1-Containing Immune Complexes in IgA NephropathyThe pathophysiology of IgA nephropathyEnzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathyEffect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA NephropathyChemoenzymatic synthesis of biotinylated nucleotide sugars as substrates for glycosyltransferases.Reconciling solvent effects on rotamer populations in carbohydrates - A joint MD and NMR analysis.Development of IgA nephropathy-like glomerulonephritis associated with Wiskott-Aldrich syndrome protein deficiency.Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia.A panel of serum biomarkers differentiates IgA nephropathy from other renal diseases.O-linked glycosylation determines the nephritogenic potential of IgA rheumatoid factor.Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy.The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.The genetics and immunobiology of IgA nephropathy.Glycosylation patterns of HIV-1 gp120 depend on the type of expressing cells and affect antibody recognition.Glomerulonephritis after hematopoietic cell transplantation: IgA nephropathy with increased excretion of galactose-deficient IgA1.Association of IgG co-deposition with serum levels of galactose-deficient IgA1 in pediatric IgA nephropathy.Genetic studies of IgA nephropathy: past, present, and future.Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease.Genome-wide association study identifies susceptibility loci for IgA nephropathy.Suppression of adiponectin by aberrantly glycosylated IgA1 in glomerular mesangial cells in vitro and in vivo.Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation.Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy.Down-regulation of core 1 beta1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1.Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability.Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathyAberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneityIncreased prevalence of anti-gliadin IgA-antibodies with aberrant duodenal histopathological findings in patients with IgA-nephropathy and related disorders.Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathyAberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy.FCGR2B and FCRLB gene polymorphisms associated with IgA nephropathy.Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.Changes in nephritogenic serum galactose-deficient IgA1 in IgA nephropathy following tonsillectomy and steroid therapy.Development of Animal Models of Human IgA NephropathyIgA nephropathy caused by unusual polymerization of IgA1 with aberrant N-glycosylation in a patient with monoclonal immunoglobulin deposition disease.Uncoupling of glomerular IgA deposition and disease progression in alymphoplasia mice with IgA nephropathySpecificity of two monoclonal antibodies against a synthetic glycopeptide, an analogue to the hypo-galactosylated IgA1 hinge region
P2860
Q24316143-8B132B38-6259-4EC5-A6CF-39E3FFEEF1DEQ24680134-AA477FB3-F91F-442C-B3BD-626631AB60AAQ26751472-B57576A6-DFA5-419A-A68F-960FE9CAE5D4Q26752555-C340AB84-B9DC-422F-BA09-0B1D4069226AQ27023866-5DBF4698-0BF4-4EBF-92A2-DBAA3E1E4F32Q28539595-2ADFC342-1E5C-4B2E-ACF5-1B86B8060C9DQ28554822-44FD2EB6-3DAB-4C05-BE05-77A7212E274CQ30831701-B9EB5200-7BB6-4652-B7B9-751D22183186Q30882071-D5034D8A-86CE-4010-A6D5-E6DFBF5A719CQ33398196-8537348F-336C-4BE0-A153-53FA40DC41B5Q33404080-213FCE1B-3420-47C3-A2AD-579BDC7E5A01Q33654763-FD6CE842-7D1E-48B0-8C4E-6FA47908D1C0Q33660620-C96574A9-247C-4DF0-B2D1-A4E08672D4D7Q33780876-3F3E3FCF-7D41-49C3-88DF-D8FEAAC47E04Q33787385-136AB419-0968-4A74-BA4E-42B1D3DE0ECDQ33872517-5ACAB2D5-CB8F-4148-871D-2A11720C6917Q33967039-2CF35ADD-A195-4900-B445-58FF705F438EQ34021364-7CFBE27E-1F58-4CFC-9EB6-B470F75EF29BQ34088820-CA87E9E5-1FB8-44E3-A3B2-F483B42DEC26Q34109845-80CCB499-44AB-48AD-9860-8DD445F9F377Q34126171-2CB5B835-6810-42CA-9A89-A71983443037Q34170453-7C428785-A494-4D14-8E16-4D464D3C36CCQ34212088-9663640B-B954-4B51-8FA5-BC2141D4D9DCQ34320745-2ABFAAE4-7010-418C-A828-691699AAABBBQ34324220-E7FB693A-E8ED-49C5-91E3-D23D21237B5AQ34340715-469495A1-799D-4D03-9CEF-25051E2E251CQ34405441-51B961A4-739E-4F34-A653-48FAC46E7A16Q34557198-5B9510FE-3256-46CD-B92B-C8E5F9032130Q34608317-573244FA-38A6-4C30-813C-6A6D862E150FQ34639222-9F7FE7BB-96CE-4787-B76C-1FCA6DC0F95BQ34655605-AACDC844-5535-4175-8AFB-72728BA48BA3Q34655791-7FF89F93-F2F9-4810-90D5-9656CE3DC48CQ34674784-28849070-04F3-42FD-971F-CBCA85BFAEE2Q34869928-CE322246-9322-4AF6-A0F0-3242F96C7322Q35022256-5F0C4230-3D76-440A-9240-C20A51D5A602Q35107938-8832AEBD-97CB-4096-8A79-1ED326BD3A2CQ35110061-02F0F8BB-C854-45D7-AED0-6E12087AF34CQ35126705-1327CFA9-2BFC-4292-8189-FB4132688334Q35151900-8693AC13-724E-4C67-8AC6-0084049BF444Q35225422-E48C38FB-8ED3-4F46-BCF4-732A986E3203
P2860
Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Circulating immune complexes i ...... gion and antiglycan antibodies
@ast
Circulating immune complexes i ...... gion and antiglycan antibodies
@en
type
label
Circulating immune complexes i ...... gion and antiglycan antibodies
@ast
Circulating immune complexes i ...... gion and antiglycan antibodies
@en
prefLabel
Circulating immune complexes i ...... gion and antiglycan antibodies
@ast
Circulating immune complexes i ...... gion and antiglycan antibodies
@en
P2093
P2860
P356
P1476
Circulating immune complexes i ...... gion and antiglycan antibodies
@en
P2093
P2860
P356
10.1172/JCI5535
P407
P577
1999-07-01T00:00:00Z